drug resistance

Open Access
Ivermectin Enhances Paclitaxel Efficacy by Overcoming Resistance Through Modulation of ABCB1 in Non-small Cell Lung Cancer
ANNA HAYASHI, KOICHIRO KAMIO, AKIHIKO MIYANAGA, KEISUKE YOSHIDA, RINTARO NORO, KUNIKO MATSUDA, TAKEHIRO TOZUKA, MIWAKO OMORI, MARIKO HIRAO, AYA FUKUIZUMI, KAKERU HISAKANE, SUSUMU TAKEUCHI, MASARU MATSUMOTO, KAZUO KASAHARA, TAKANORI AMANO, KAZUFUMI HONDA and MASAHIRO SEIKE

Anticancer Research December 2024, 44 (12) 5271-5282; DOI: https://doi.org/10.21873/anticanres.17355
You have access
Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma
SONEXAI KIDOIKHAMMOUAN, WORACHART LERT-ITTHIPORN, RAKSAWAN DEENONPOE, CHARUPONG SAENGBOONMEE, SUMALEE OBCHOEI, SOPIT WONGKHAM and WUNCHANA SEUBWAI

Anticancer Research December 2024, 44 (12) 5393-5404; DOI: https://doi.org/10.21873/anticanres.17366
Open Access
Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma
SHUMPEI OKIMURA, NAOHIRO NISHIDA, HIDEKAZU TAKAHASHI, YUHKI YOKOYAMA, HIROYUKI YAMAMOTO, ATSUSHI HAMABE, TAKAYUKI OGINO, NORIKATSU MIYOSHI, HIDENORI TAKAHASHI, MAMORU UEMURA, SHOGO KOBAYASHI, MASAKI MORI, YUICHIRO DOKI, HIDETOSHI EGUCHI and HIROFUMI YAMAMOTO

Anticancer Research November 2024, 44 (11) 4737-4749; DOI: https://doi.org/10.21873/anticanres.17300
You have access
MiR-140-3p Improves Sensitivity to Docetaxel by Suppressing PD-L1/ABCG2/MVP Expression in Lung Adenocarcinoma
MINJI KWON, DAYEON LIM, JAYEON PARK, WORLD GIL, JIWOO JUNG, SUYEON JUNG, CHAEEON KIM, MINJEONG GO, YE HWANG CHEONG, HEE SUN PARK, YONG-BIN EOM and SIN-AYE PARK

Anticancer Research October 2024, 44 (10) 4283-4299; DOI: https://doi.org/10.21873/anticanres.17258
Open Access
Identification of BRAF Inhibitor Resistance–associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening
XUAN WEN, MIN HAN, MASAKI HOSOYA, RIKA TOSHIMA, MAI ONISHI, TOMOAKI FUJII, SHIGEO YAMAGUCHI and SHUNSUKE KATO

Anticancer Research June 2024, 44 (6) 2349-2358; DOI: https://doi.org/10.21873/anticanres.17042
You have access
Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells
SUNG-CHUL LIM, TAE-BUM LEE and SONG IY HAN

Anticancer Research June 2024, 44 (6) 2587-2595; DOI: https://doi.org/10.21873/anticanres.17064
Open Access
High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
TAKASHI HIGUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research October 2023, 43 (10) 4277-4284; DOI: https://doi.org/10.21873/anticanres.16622
Open Access
Targeting Glypican-1 Reverses Resistance to 5-Fluorouracil in Esophageal Adenocarcinoma Cells
AKSHAY PRATAP, ANDREA QUALMAN, HEDLUND GARRETT, ERLINDA THE, ARGUDIT CHAUHAN, JUAN P. IDROVO, LINLING CHENG, SACHIN WANI, ROBERT ALEXANDER MEGUID and XIANZHONG MENG

Anticancer Research August 2023, 43 (8) 3411-3418; DOI: https://doi.org/10.21873/anticanres.16516
You have access
Acquired AKT-inhibitor Resistance Is Mediated by ATP-binding Cassette Transporters in Endometrial Carcinoma
SHOJI TAKAGI, TAKAFUMI ONISHI, TSUYOSHI TAKASHIMA, KAZUKI SHIBAHARA and MICHIHIRO MORI

Anticancer Research June 2023, 43 (6) 2501-2507; DOI: https://doi.org/10.21873/anticanres.16417
You have access
ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies
YI MING YANG, FIONA RUGE, KE JI, SHUQIN JIA, YONGNING JIA, ANDREW J. SANDERS, JIAFU JI and WEN G. JIANG

Anticancer Research April 2023, 43 (4) 1463-1475; DOI: https://doi.org/10.21873/anticanres.16295

Main menu

User menu

Search

drug resistance

Pages